Tudor Investment Corp’s Applied Therapeutics APLT Stock Holding History

Tudor Investment Corp’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-57,454	Closed	-$5.75K	–	3568
2025 Q4	$5.75K	Hold	57,454	–	–	﹤0.01%	3422
2025 Q3	$34.8K	Hold	57,454	–	–	﹤0.01%	3282
2025 Q2	$17.9K	Hold	57,454	–	–	﹤0.01%	3173
2025 Q1	$28.1K	Hold	57,454	–	–	﹤0.01%	2967
2024 Q4	$49.2K	Buy	+57,454	New	+$360K	﹤0.01%	2932

Tudor Investment Corp's APLT Position: Q1 2026 in Review

Tudor Investment Corp sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 57,454 shares — an estimated $5.75K sold.

Tudor Investment Corp first reported a position in APLT in Q4 2024 and held it in 5 quarters. The position peaked at $49.2K in Q4 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Tudor Investment Corp reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Tudor Investment Corp sold 57,454 Applied Therapeutics shares in Q1 2026, an estimated $5.75K.
Tudor Investment Corp first reported a position in Applied Therapeutics in Q4 2024 and held it in 5 quarters.
Tudor Investment Corp's Applied Therapeutics position peaked at $49.2K in Q4 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.